Your browser doesn't support javascript.
loading
Patient satisfaction, health care resource utilization, and acute headache medication use with galcanezumab: results from a 12-month open-label study in patients with migraine.
Ford, Janet H; Foster, Shonda A; Stauffer, Virginia L; Ruff, Dustin D; Aurora, Sheena K; Versijpt, Jan.
Afiliación
  • Ford JH; Eli Lilly and Company, Indianapolis, IN 46225, USA, ford_janet@lilly.com.
  • Foster SA; Eli Lilly and Company, Indianapolis, IN 46225, USA, ford_janet@lilly.com.
  • Stauffer VL; Eli Lilly and Company, Indianapolis, IN 46225, USA, ford_janet@lilly.com.
  • Ruff DD; Eli Lilly and Company, Indianapolis, IN 46225, USA, ford_janet@lilly.com.
  • Aurora SK; Eli Lilly and Company, Indianapolis, IN 46225, USA, ford_janet@lilly.com.
  • Versijpt J; Department of Neurology - Headache and Facial Pain Clinic, Vrije Universiteit Brussel (VUB), Universitair Ziekenhuis Brussel (UZ Brussel), 1090 Brussels, Belgium.
Patient Prefer Adherence ; 12: 2413-2424, 2018.
Article en En | MEDLINE | ID: mdl-30519007

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Idioma: En Revista: Patient Prefer Adherence Año: 2018 Tipo del documento: Article

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Idioma: En Revista: Patient Prefer Adherence Año: 2018 Tipo del documento: Article